Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Jocelyn Bosse, Alessandro Cerri, Oliver Fairhurst and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Anastasiia Kyrylenko (Book Review Editor).

InternKats: Simone Lorenzi and Asude Sena Moya.
Defining the undefinable: The challenges and opportunities for cell therapy IP Defining the undefinable: The challenges and opportunities for cell therapy IP Reviewed by Dr Rose Hughes on Tuesday, May 13, 2025 Rating: 5
AI and Copyright - the Kidron Amendments AI and Copyright - the Kidron Amendments Reviewed by Oliver Fairhurst on Tuesday, May 13, 2025 Rating: 5
The never-ending story of Brexit – Chapter: EUIPO v Nowhere – Act I: The Advocate General’s Opinion The never-ending story of Brexit – Chapter: EUIPO v Nowhere – Act I: The Advocate General’s Opinion Reviewed by Marcel Pemsel on Tuesday, May 13, 2025 Rating: 5
[Guest Post] A shotgun revocation? Did the South African court jump the gun in Regents of the University of California v Eurolab & Dis-Chem? [Guest Post] A shotgun revocation? Did the South African court jump the gun in Regents of the University of California v Eurolab & Dis-Chem? Reviewed by Simone Lorenzi on Monday, May 12, 2025 Rating: 5
[Guest Post] Out the Door, Back In Through the Grille: Warsaw Court Reverses Audi Advantage [Guest Post] Out the Door, Back In Through the Grille: Warsaw Court Reverses Audi Advantage Reviewed by Marcel Pemsel on Sunday, May 11, 2025 Rating: 5
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 Reviewed by Annsley Merelle Ward on Friday, May 09, 2025 Rating: 5
Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) Reviewed by Dr Rose Hughes on Thursday, May 08, 2025 Rating: 5
Of tables and other furniture: AG Szpunar advises CJEU on originality (but also proposes adoption of recognizability test for infringement) Of tables and other furniture: AG Szpunar advises CJEU on originality (but also proposes adoption of recognizability test for infringement) Reviewed by Eleonora Rosati on Thursday, May 08, 2025 Rating: 5

Tuesday Tiddlywinks

The IPKat is back with the weekly post of miscellany news and opportunities. As always, do not forget to regularly check our page of forthco...
- Tuesday, May 06, 2025
Tuesday Tiddlywinks Tuesday Tiddlywinks Reviewed by Eleonora Rosati on Tuesday, May 06, 2025 Rating: 5
An imaginative sign for smart houses qualifies for EU trade mark registration An imaginative sign for smart houses qualifies for EU trade mark registration Reviewed by Söğüt Atilla on Tuesday, May 06, 2025 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.